E. Feliciangeli

Treatment of Microscopic Disease with Hyperthermic Intraoperative Intraperitoneal Chemotherapy After Complete Cytoreduction Improves Disease-Free Survival in Patients with Stage IIIC/IV Ovarian Cancer

Pedro Antonio Cáscales-Campos, Jesús Gil, E. Gil et al. · Annals of Surgical Oncology · 2014 · 90 citations

Medicine, Oncology, Surgery +17

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Ángela Lamarca et al. · Journal of Clinical Oncology · 2019 · 76 citations · Full text

Medicine, Endocrinology, Oncology +14

Use of 18 F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue

Víctor López‐López, P.A. Cascales-Campos, Jesús Gil et al. · European Journal of Radiology · 2016 · 72 citations

Medicine, Oncology, Surgery +16

The Role of Hyperthermic Intraperitoneal Chemotherapy Using Paclitaxel in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer Patients with Microscopic Residual Disease after Cytoreduction

Pedro Antonio Cáscales-Campos, Jesús Gil, E. Feliciangeli et al. · Annals of Surgical Oncology · 2014 · 47 citations

Medicine, Gynecology, Oncology +13

Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC–IV ovarian cancer. Critical analysis in elderly patients

P.A. Cascales-Campos, Jesús Gil, E. Gil et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2014 · 36 citations

Medicine, Oncology, Surgery +9